StonvexLoading…
StonvexStonvexStonvexCore line items from CHD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.47B | $6.20B | $4.56B | $2.97B |
Operating Income | $291.00M | $1.08B | $811.60M | $557.00M |
Net Income | $216.30M | $736.80M | $593.30M | $191.00M |
EPS (Diluted) | $0.91 | $3.02 | $2.41 | $1.66 |
Total Assets | $9.01B | $8.91B | $9.14B | $8.79B |
Total Liabilities | $4.82B | $4.91B | $4.92B | $4.39B |
Cash & Equivalents | $503.40M | $409.00M | $305.30M | $923.20M |
Free Cash Flow OCF − CapEx | $142.90M | $1.09B | Not available | Not available |
Shares Outstanding | 238.10M | 244.30M | 245.90M | 247.20M |